Inventor · disambiguated record
Yong-Jin Wu
Also filed as: WU YONG · WU YONG-JIN
49 granted patents·11 pending applications·401 citations·filing 1998–2024
98Inventor score
Files withBRISTOL MYERS SQUIBB CO26PFIZER14BOY KENNETH M4SHANGHAI ALLIST PHARMACEUTICALS CO LTD2UNIV VANDERBILT2
Top patents by PatentIndex Score
60 records- 0195US11767322B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 26, 2023·3 cites·66 claims
- 0294US8486952B2Compounds for the reduction of β-amyloid productionBOY KENNETH M·Filed 2010·Granted Jul 16, 2013·34 cites·15 claims
- 0393US8637525B2Compounds for the reduction of beta-amyloid productionBOY KENNETH M·Filed 2011·Granted Jan 28, 2014·39 cites·5 claims
- 0492US7098203B2Homopiperidine derivatives as NK-1 antagonistsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 29, 2006·13 cites·10 claims
- 0592US7045551B21-aryl-2-hydroxyethyl amides as potassium channel openersBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 16, 2006·35 cites·8 claims
- 0691US7138423B2Arylpyrrolidine derivatives as NK-1 /SSRI antagonistsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Nov 21, 2006·10 cites·10 claims
- 0788US10072002B2Pyridinylaminopyrimidine derivatives, preparation process and use thereofSHANGHAI ALLIST PHARMACEUTICALS INC·Filed 2015·Granted Sep 11, 2018·6 cites·21 claims
- 0884US7494986B2Cycloalkylamine derivatives as NK-1/SSRI antagonistsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Feb 24, 2009·4 cites·7 claims
- 0983US10526323B2Indazole and azaindazole substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunctionUNIV VANDERBILT·Filed 2016·Granted Jan 7, 2020·2 cites·45 claims
- 1083US7390925B2Oxime-containing acyl guanidines as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jun 24, 2008·5 cites·9 claims
- 1182US8598161B2Compounds for the reduction of beta-amyloid productionWU YONG-JIN·Filed 2012·Granted Dec 3, 2013·5 cites·9 claims
- 1282US7276631B2Cyclopentylamine and cyclohexylamine derivatives as NK-1/SSRI antagonistsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Oct 2, 2007·4 cites·13 claims
- 1382US6933308B2Aminoalkyl thiazole derivatives as KCNQ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 23, 2005·11 cites·11 claims
- 1482US6777543B213-methyl erythromycin derivativesPFIZER·Filed 2003·Granted Aug 17, 2004·16 cites·5 claims
- 1579US12110290B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Oct 8, 2024·0 cites·14 claims
- 1679US10227343B2Isoquiniline and napthalene-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunctionUNIV VANDERBILT·Filed 2016·Granted Mar 12, 2019·3 cites·27 claims
- 1778US6498146B1Erythromycin derivativesPFIZER·Filed 2000·Granted Dec 24, 2002·8 cites·36 claims
- 1878US2024425505A1Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1976US8349880B2Bicyclic compounds for the reduction of beta-amyloid productionBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Jan 8, 2013·4 cites·6 claims
- 2076US6900210B2Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openersBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 31, 2005·7 cites·7 claims
- 2176US6831080B2Cinnamide derivatives as KCNQ potassium channel modulatorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Dec 14, 2004·11 cites·27 claims
- 2275US7144881B2Arylcyclopropylcarboxylic amides as potassium channel openersBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Dec 5, 2006·5 cites·7 claims
- 2374US6825171B2Erythromycin derivativesPFIZER·Filed 2003·Granted Nov 30, 2004·5 cites·16 claims
- 2474US6664238B1Carbamate and carbazate ketolide antibioticsPFIZER·Filed 1999·Granted Dec 16, 2003·35 cites·10 claims
- 2573US7087609B23-(pyridinyl-piperazin-1-yl)-phenylethyl amides as potassium channel openersBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 8, 2006·5 cites·7 claims
- 2671US8637523B2Compounds for the reduction of beta-amyloid productionBOY KENNETH M·Filed 2011·Granted Jan 28, 2014·2 cites·12 claims
- 2770US6300316B1C-4 substituted macrolide antibioticsPFIZER·Filed 1999·Granted Oct 9, 2001·25 cites·11 claims
- 2870US6262030B1Erythromycin derivativesPFIZER·Filed 1999·Granted Jul 17, 2001·26 cites·30 claims
- 2969US7135472B23-Heterocyclic benzylamide derivatives as potassium channel openersBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Nov 14, 2006·4 cites·7 claims
- 3065USRE48687EPyridinylaminopyrimidine derivatives, preparation process and use thereofSHANGHAI ALLIST PHARMACEUTICALS CO LTD·Filed 2015·Granted Aug 17, 2021·1 cites·22 claims
- 3165US6875771B2Pyridopyrimidine derivatives as 5-HT6 antagonistsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Apr 5, 2005·3 cites·9 claims
- 3265US6291656B1Tricyclic erythromycin derivativesPFIZER·Filed 1998·Granted Sep 18, 2001·19 cites·12 claims
- 3364US6159945A9-amino-3-keto erythromycin derivativesPFIZER·Filed 1998·Granted Dec 12, 2000·18 cites·14 claims
- 3459US6800590B22-Pyrimidinyloxy-n-aryl-benzylamine derivatives,their processes and usesSHANGHAI INST ORGANIC CHEM·Filed 2001·Granted Oct 5, 2004·3 cites·10 claims
- 3558US2013178462A1Compounds for the reduction of beta-amyloid productionBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 3656US6162794AErythromycin derivativesPFIZER·Filed 1998·Granted Dec 19, 2000·10 cites·12 claims
- 3755US7678784B2Oxime-containing macrocyclic acyl guanidines as β-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Mar 16, 2010·0 cites·8 claims
- 3853US7772221B2Diaminopropane derived macrocycles as inhibitors of β amyloid productionBRISTOL MEYERS SQUIBB CO·Filed 2008·Granted Aug 10, 2010·0 cites·13 claims
- 3953US6248719B1Tricyclic 3-keto derivatives of 6-O-methylerthromycinPFIZER·Filed 1999·Granted Jun 19, 2001·11 cites·17 claims
- 4052US10919878B2MCT4 inhibitors and uses thereofCHARLES R DREW UNIV OF MEDICINE AND SCIENCE·Filed 2019·Granted Feb 16, 2021·0 cites·9 claims
- 4151US2015336975A1Compounds for the reduction of beta-amyloid productionBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 4250USRE49851EPyridinylaminopyrimidine derivatives, preparation process and use thereofSHANGHAI ALLIST PHARMACEUTICALS CO LTD·Filed 2015·Granted Feb 27, 2024·0 cites·25 claims
- 4350US2002151507A19-oxime erythromycin derivativesFiled 2002·Application pending·0 cites
- 4450US2015152089A1Compounds for the reduction of beta-amyloid productionBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 4547US7476764B2Phenylcarboxyamides as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jan 13, 2009·0 cites·9 claims
- 4647US2003100742A1Erythromycin a derivativesPFIZER·Filed 2002·Application pending·0 cites
- 4746US2002061856A1Novel tricyclic erythromycin derivativesFiled 2000·Application pending·0 cites
- 4846US2002061857A19-amino-3-oxo erythromycin derivativesFiled 2000·Application pending·0 cites
- 4945US2003100518A113-Methyl erythromycin derivativesFiled 2000·Application pending·0 cites
- 5044US11618753B2Aminopyrrolotriazines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Apr 4, 2023·0 cites·9 claims
Showing the top 50 of 60 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yong-Jin Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →